Cargando…
Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
Lysosomal storage diseases (LSDs) are a group of genetic disorders due to defects in any aspect of lysosomal biology. During the past two decades, different approaches have been introduced for the treatment of these conditions. Among them, enzyme replacement therapy (ERT) represented a major advance...
Autor principal: | Parenti, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378140/ https://www.ncbi.nlm.nih.gov/pubmed/20049730 http://dx.doi.org/10.1002/emmm.200900036 |
Ejemplares similares
-
Clinical and Histologic Evaluation of Platelet-Rich Fibrin Accelerated Epithelization of Gingival Wound
por: Bansal, Mansi, et al.
Publicado: (2016) -
RNAi-based therapeutics–current status, challenges and prospects
por: Tiemann, Katrin, et al.
Publicado: (2009) -
Imaging metabolic syndrome
por: Han, Weiping, et al.
Publicado: (2010) -
Role of Combined Circumareolar Skin Excision and Liposuction in Management of High grade Gynaecomastia
por: Sarkar, Arindam, et al.
Publicado: (2014) -
TORC2—a new player in genome stability
por: Weisman, Ronit, et al.
Publicado: (2014)